Neuronetics, Inc. (STIM) stock
STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.28+0.03 (+2.40%)
Close on Nov 17, 2026Market cap $97.53MP/E –Yield –
Neuronetics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Neuronetics's total debt was $61.52M at Jun 30, 2026. For fiscal 2025 it was $65.81M, up 19.3% from the year before. The highest annual figure on record is $65.81M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.81M | +19.3% |
| FY2024 | Dec 31, 2024 | $55.15M | -7.0% |
| FY2023 | Dec 31, 2023 | $59.28M | +64.9% |
| FY2022 | Dec 31, 2022 | $35.95M | +1.8% |
| FY2021 | Dec 31, 2021 | $35.34M | +2.1% |
| FY2020 | Dec 31, 2020 | $34.62M | +11.1% |
| FY2019 | Dec 31, 2019 | $31.15M | +2.5% |
| FY2018 | Dec 31, 2018 | $30.40M | +2.8% |
| FY2017 | Dec 31, 2017 | $29.56M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $61.52M | +10.8% |
| Q1 FY2026 | Mar 31, 2026 | $61.30M | +10.8% |
| Q4 FY2025 | Dec 31, 2025 | $65.81M | +19.3% |
| Q3 FY2025 | Sep 30, 2025 | $65.67M | +42.8% |
| Q2 FY2025 | Jun 30, 2025 | $55.54M | -7.1% |
| Q1 FY2025 | Mar 31, 2025 | $55.34M | -6.9% |
| Q4 FY2024 | Dec 31, 2024 | $55.15M | -7.0% |
| Q3 FY2024 | Sep 30, 2024 | $46.00M | +24.8% |
| Q2 FY2024 | Jun 30, 2024 | $59.76M | +62.8% |
| Q1 FY2024 | Mar 31, 2024 | $59.44M | +62.2% |
| Q4 FY2023 | Dec 31, 2023 | $59.28M | +64.9% |
| Q3 FY2023 | Sep 30, 2023 | $36.85M | +3.1% |
| Q2 FY2023 | Jun 30, 2023 | $36.71M | +3.2% |
| Q1 FY2023 | Mar 31, 2023 | $36.64M | +3.4% |
| Q4 FY2022 | Dec 31, 2022 | $35.95M | +1.8% |
| Q3 FY2022 | Sep 30, 2022 | $35.76M | +1.9% |
| Q2 FY2022 | Jun 30, 2022 | $35.59M | +1.8% |
| Q1 FY2022 | Mar 31, 2022 | $35.44M | +1.9% |
| Q4 FY2021 | Dec 31, 2021 | $35.34M | +2.1% |
| Q3 FY2021 | Sep 30, 2021 | $35.10M | +1.6% |
| Q2 FY2021 | Jun 30, 2021 | $34.94M | +1.7% |
| Q1 FY2021 | Mar 31, 2021 | $34.79M | +1.7% |
| Q4 FY2020 | Dec 31, 2020 | $34.62M | +11.1% |
| Q3 FY2020 | Sep 30, 2020 | $34.54M | +11.6% |
| Q2 FY2020 | Jun 30, 2020 | $34.37M | +11.8% |
| Q1 FY2020 | Mar 31, 2020 | $34.21M | +11.9% |
| Q4 FY2019 | Dec 31, 2019 | $31.15M | +2.5% |
| Q3 FY2019 | Sep 30, 2019 | $30.95M | +2.5% |
| Q2 FY2019 | Jun 30, 2019 | $30.76M | +2.5% |
| Q1 FY2019 | Mar 31, 2019 | $30.57M | +3.4% |
| Q4 FY2018 | Dec 31, 2018 | $30.40M | – |
| Q3 FY2018 | Sep 30, 2018 | $30.20M | – |
| Q2 FY2018 | Jun 30, 2018 | $30.00M | – |
| Q4 FY2017 | Dec 31, 2017 | $29.56M | – |
See a number that looks wrong?